TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04421456

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“This study was terminated based on a business decision by the Sponsor.”

The sponsor’s own words in the registry.

Life of this trial

20202021202220232024Registered2020-05-27Started2020-08-18Stopped2022-03-16Results posted2023-06-15

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Jazz Pharmaceuticals
Sponsor type
Industry
Conditions
Schizophrenia
Interventions
GWP42003-P; Placebo
Participants
95
Sites
39
Countries
Poland, Serbia, Spain, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.